Cargando…
New Insights into the Role of the Trypanosoma cruzi Aldo-Keto Reductase TcAKR
Chagas disease is a zoonotic infectious disease caused by the protozoan parasite Trypanosoma cruzi. It is distributed worldwide, affecting around 7 million people; there is no effective treatment, and it constitutes a leading cause of disability and premature death in the Americas. Only two drugs ar...
Autores principales: | Díaz-Viraqué, Florencia, Chiribao, María Laura, Paes-Vieira, Lisvane, Machado, Matias R., Faral-Tello, Paula, Tomasina, Ramiro, Trochine, Andrea, Robello, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860839/ https://www.ncbi.nlm.nih.gov/pubmed/36678433 http://dx.doi.org/10.3390/pathogens12010085 |
Ejemplares similares
-
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
por: Trochine, Andrea, et al.
Publicado: (2014) -
Aldo-keto reductase (AKR) superfamily: Genomics and annotation
por: Mindnich, Rebekka D, et al.
Publicado: (2009) -
Genome-wide chromatin interaction map for Trypanosoma cruzi
por: Díaz-Viraqué, Florencia, et al.
Publicado: (2023) -
Old Yellow Enzyme from Trypanosoma cruzi Exhibits In Vivo Prostaglandin F(2)α Synthase Activity and Has a Key Role in Parasite Infection and Drug Susceptibility
por: Díaz-Viraqué, Florencia, et al.
Publicado: (2018) -
Maxicircle architecture and evolutionary insights into Trypanosoma cruzi complex
por: Berná, Luisa, et al.
Publicado: (2021)